August 31, 2018

August 31, 2018

State cancer center program has invested more than $300 million since 2014

WTVT – Aug. 30

The governor was at Moffitt Cancer Center to highlight the prom that took effect in 2014 to increase funding to cancer centers.


Cancer Research Funding

WFLA – Aug. 30

I look forward to the day that Moffitt will be the number one cancer center in the world. I believe that will happen,” said Gov. Rick Scott.


Scott calls DeSantis’ ‘monkey’ comment ‘inartful’

Tampa Bay Times – Aug. 30

Gov. Rick Scott said Thursday that GOP gubernatorial nominee Ron DeSantis was "inartful" in comments about rival Andrew Gillum that critics say were racial.


Governor Rick Scott speaks out on Desantis’ comments

News 13 – Aug. 30

The governor was in Tampa to praise the work being done at Moffitt Cancer center  but the focus of the visit became the election and Desantis.  When asked if he believed the gubernatorial candidates should apologize, Governor Scott said that's a choice Desantis would have to make.


Rick Scott Showcases More than $300 Million to Help Cancer Centers Across Florida

Topix – Aug. 31

At an event at Moffitt Cancer Center on Thursday, Gov. Rick Scott showcased the state's investments in fighting cancer in recent years. Also posted to Sunshine State News and News Talk Florida.


Gov. Scott: Since 2014, We Have Invested More Than $300 Million in Cancer Centers

Capital Soup – Aug. 30

Governor Rick Scott today highlighted more than $300 million invested in Florida’s cancer centers since 2014 while at Moffitt Cancer Center.


Sunburn — The morning read of what’s hot in Florida politics – Aug. 30

Gov. Scott will visit Moffitt Cancer Center to highlight $300 million in funding since 2014 for research and treatment, 10:30 a.m., 12902 USF Magnolia Dr., Tampa.


Shannon’s Walk for ACC CURE benefitting adrenal cancer research at Moffitt Cancer Center

Tampa Bay Newswire – Aug. 30

Unlike traditional walks, participants will walk a dedicated route for 42 minutes, a minute each year of Shannon’s life cut too short by adrenal cancer.


Anne White Promoted to President of Lilly Oncology

Medical Health News - Aug. 30

White also worked in biotech, having founded and led a startup company in oncology drug development with partnerships with the Moffitt Cancer Center and the National Cancer Institute.


Dr. Bello on Biomarkers in Follicular Lymphoma

OncLive – Aug. 30

Celeste Bello, MD, hematologist/oncologist, Moffitt Cancer Center, discusses investigational biomarkers in follicular lymphoma.


Prescient Therapeutics expands PTX-200 oncology study – Aug. 30

The study is led by world-renowned AML expert, Professor Jeff Lancet, at the H. Lee Moffitt Cancer Centre in Florida, and including the Yale Cancer Center and Kansas University Medical Centre.


Success of proton therapy may depend on who pays for it – Aug. 30

Along with colleagues Gregory Johnstone of the Ochsner Cancer Institute in New Orleans and Dr. Peter Johnstone of the Moffitt Cancer Center in Tampa, FL, Kerstiens sought to identify what factors best contribute to a proton therapy center's financial health in the current healthcare environment.


Local organizations aiding Hurricane Maria refugees 'not surprised' by sharply higher death toll

WTSP – Aug. 29

“I helped one man who came here from Puerto Rico with cancer. His families always says to me, 'If we would have stayed in Puerto Rico, he would not have made it.' Now he’s getting treatment at Moffitt Cancer Center.”


Dr. David Sugarbaker, Mesothelioma Treatment Pioneer, Dies at 65 – Aug. 29

Dr. Jacques Fontaine, a thoracic surgeon who trained under Sugarbaker, started the Mesothelioma Research and Treatment Center at Moffitt Cancer Center in Tampa.


Axicabtagene ciloleucel approved by the EC for the treatment of DLBCL and PMBC

Lymphoma Hub – Aug. 28

Professor Frederik Locke, H. Lee Moffitt Cancer Center, Tampa, Florida, commented on the duration of response from the study at the annual meeting of the American Society of Clinical Oncology in Chicago, June 2018. "What we found was that for patients in a partial response or complete response, at three months after a single infusion of CAR-T therapy, 80% of those patients remained in remission one year after the therapy was given." He added that "many of those responses deepened over time."


Pet Therapy Dogs at Moffitt

ABC Action News – Aug. 27

Pet therapy dogs provide comfort and companionship to cancer patients at Moffitt Cancer Center. 


Syracuse Football: Rex Culpepper details his journey battling cancer – Aug. 27

While he didn’t ring the bell at the Moffitt Cancer Center in Tampa prior to his surprising appearance in the spring showcase, it did provide him the final rejuvenation required to push through the final nine weeks of his treatment.


Tampa company focused on cancer treatment launches first human clinical study

Tampa Bay Business Journal – Aug. 28

The company collaborated with the Cutaneous Oncology Program at Moffitt Cancer Center on preclinical research before getting the go-ahead from the U.S. Food and Drug Administration for the clinical study.


Biotech firm advances skin cancer treatment program

Business Observer – Aug. 27

According to a press release, the U.S. Food & Drug Administration has approved the tests, which are the product of a collaboration between Morphogenesis and the cutaneous oncology program at Tampa’s Moffitt Cancer Center.


MacDonald Training Center seeks help in patching up leaky roof

WTVT – Aug. 27

They are always coming up with new ways to make a difference. They now have a hospitality training room donated by Moffitt Cancer Center and they have a new EXCEL program (Excellence in Computer Education and Learning) for people on the autism spectrum.


Doctors: Breakthroughs May Soon Defeat the Cancer That Killed McCain

Wheaton Business Journal – Aug. 26

“Glioblastoma is considered to be advanced by the time of diagnosis,” explains Dr. Solmaz Sahebjam, a neuro-oncologist at the Moffitt Cancer Center in Tampa, Fla. “At this time, it is not curable, meaning there’s no way to get rid of it. The aim is to control it as long as possible.” Also posted to, NewsMax.


Blood Test Measuring ctDNA Predictive of DLBCL Tx Response

MedPage Today – Aug. 25

Asked for his perspective, Frederick Locke, MD, program co-leader of immunology at Moffitt Cancer Center in Tampa, Fla., told MedPage Today that this type of prognostic tool could be "very useful" in assessing the performance of chimeric antigen receptor (CAR) T-cell therapy in DLBCL patients.


University Mall could be reborn as an urban village-style life sciences and technology park

Tampa Bay Business Journal – Aug. 24

The vision has a synergy with the mall's neighbors — H. Lee Moffitt Cancer Center, James A Haley Veterans Hospital, Florida Hospital Tampa and the University of South Florida — but it's an incredibly lofty vision for 96 acres in the middle of one of Tampa's least walkable corridors.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.